|
Re: One week later....
|
1
|
Resverlogix Corp.
|
May 21, 2021 06:59AM
|
|
Re: One week later....
|
11
|
Resverlogix Corp.
|
May 21, 2021 06:54AM
|
|
NY Times "Most Promising" Updated May 18
|
|
Resverlogix Corp.
|
May 21, 2021 05:41AM
|
|
Synairigen News
|
|
Resverlogix Corp.
|
May 21, 2021 05:13AM
|
|
Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
4
|
Resverlogix Corp.
|
May 21, 2021 02:08AM
|
|
Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
4
|
Resverlogix Corp.
|
May 21, 2021 02:01AM
|
|
In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease
|
3
|
Resverlogix Corp.
|
May 21, 2021 01:54AM
|
|
Re: One week later....
|
3
|
Resverlogix Corp.
|
May 20, 2021 12:15PM
|
|
Re: Presentation is up again
|
1
|
Resverlogix Corp.
|
May 18, 2021 12:46PM
|
|
Re: Presentation is up again
|
1
|
Resverlogix Corp.
|
May 18, 2021 12:42PM
|
|
Presentation is up again
|
3
|
Resverlogix Corp.
|
May 18, 2021 02:19AM
|
|
Alz Forum article from April
|
3
|
Resverlogix Corp.
|
May 17, 2021 02:40AM
|
|
Re: Presentation
|
4
|
Resverlogix Corp.
|
May 13, 2021 05:44PM
|
|
Re: Rough Transcript RVX 21_05_12_PBA_at_Noon...
|
2
|
Resverlogix Corp.
|
May 13, 2021 05:35PM
|
|
Re: Rough Transcript RVX 21_05_12_PBA_at_Noon...
|
6
|
Resverlogix Corp.
|
May 13, 2021 08:08AM
|
|
Rough Transcript RVX 21_05_12_PBA_at_Noon...
|
10
|
Resverlogix Corp.
|
May 13, 2021 07:56AM
|
|
Re: Presentation May 12th
|
5
|
Resverlogix Corp.
|
May 11, 2021 01:16AM
|
|
Crack down on Reporting failures in clinical trials .gov?
|
2
|
Resverlogix Corp.
|
May 09, 2021 02:57PM
|
|
Re: Presentation May 12th
|
9
|
Resverlogix Corp.
|
May 09, 2021 01:35PM
|
|
Re: Trial delay
|
2
|
Resverlogix Corp.
|
May 04, 2021 12:27PM
|
